The NASH Epidemic: Highlights from the AMCP 2023 Symposium
Host: Mazen Noureddin, MD
\n\n\n \n
Nonalcoholic steatohepatitis (NASH) is an epidemic with enormous health and economic implications. Join us for our chairman\u2019s perspective on best practices to identify, screen, and refer patients. Dr. Mazen Noureddin also examines some of the emerging therapeutics that may change your approach to NASH.